Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
AXM Pharma Inc. (AXMP) had Consolidated Net Income/Loss of $-0.02M for the most recently reported fiscal quarter, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
$-0.02M |
|
-- |
|
-- |
|
$0.02M |
|
$-0.02M |
|
$-0.00M |
|
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
|
Consolidated Net Income/Loss |
$-0.02M |
$-0.02M |
|
$-0.02M |
|
$-0.02M |
|
158.60M |
|
158.60M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.03M |
|
-- |
|
-- |
|
$0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.02M |
|
158.60M |
|
| Cash Flow Statement Financials | |
$0.01M |
|
-- |
|
$0.01M |
|
-- |
|
-- |
|
$0.02M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-0.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$0.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
70.72% |
|
60.21% |
|
-- |
|
80.38% |
|
$-0.00 |
|
$0.00 |
|
$0.00 |
|